We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New Hope for Javelin's Pain Candidate but Safety Concerns Remain

News   Feb 23, 2010

 
New Hope for Javelin's Pain Candidate but Safety Concerns Remain
 
 
 

RELATED ARTICLES

Antidepressant Based on Ketamine Gets Backing from FDA Advisory Group

News

A form of the hallucinogenic party drug ketamine has cleared one of the final hurdles toward clinical use as an antidepressant. During a meeting at the US Food and Drug Administration (FDA) in Silver Spring, Maryland, an independent advisory panel voted 14-2 in favor of recommending a compound known as esketamine for use in treating depression.

READ MORE

Insights on the Role of Estrogen in Type 2 Diabetes

News

This study provides insights into the mechanism by which estrogen can decrease insulin resistance and the production of glucose, reducing incidences of Type 2 diabetes mellitus.

READ MORE

Method Maximizes the Potential of Miniature Kidneys

News

A method for growing kidney organoids under flow enhances their vascularization and maturation, increasing their potential for drug testing and regenerative medicine.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE